T. Rowe Price Associates’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,078
| Closed | -$14K | – | 3117 |
|
|
2025
Q1 | $14K | Hold |
16,078
| – | – | ﹤0.01% | 3017 |
|
|
2024
Q4 | $28K | Hold |
16,078
| – | – | ﹤0.01% | 2972 |
|
|
2024
Q3 | $46K | Hold |
16,078
| – | – | ﹤0.01% | 2937 |
|
|
2024
Q2 | $38K | Hold |
16,078
| – | – | ﹤0.01% | 2883 |
|
|
2024
Q1 | $48K | Buy |
16,078
+4,239
| +36% | +$12.7K | ﹤0.01% | 2876 |
|
|
2023
Q4 | $36K | Buy |
11,839
+1,389
| +13% | +$4.22K | ﹤0.01% | 2842 |
|
|
2023
Q3 | $34K | Buy |
10,450
+438
| +4% | +$1.43K | ﹤0.01% | 2817 |
|
|
2023
Q2 | $39K | Buy |
+10,012
| New | +$39K | ﹤0.01% | 2822 |
|